Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lea Dörner
Institution:
The Netherlands Cancer Institute
Observed institutions:
The Netherlands Cancer Institute,
Oncode Institute
ORCID:
0009-0006-8975-1012
Observed ORCID:
0009-0006-8975-1012
OpenAlex ID:
A5121478814
Watching cancer begin: emerging tools to visualize the first steps of tumorigenesis
2026
·
Hendrik A. Messal
, Larissa Mourao
, et al.
·
Trends in cancer
·
3
C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3
2025
·
Julia Yemelyanenko
, Jinhyuk Bhin
, et al.
·
Cancer Research
·
2
Supplementary Data S1 from C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3
2026
·
Julia Yemelyanenko
, Jinhyuk Bhin
, et al.
Supplementary Table S2 from C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3
2026
·
Julia Yemelyanenko
, Jinhyuk Bhin
, et al.
Supplementary Methods S9 from C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3
2026
·
Julia Yemelyanenko
, Jinhyuk Bhin
, et al.
Supplementary Methods S3 from C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3
2026
·
Julia Yemelyanenko
, Jinhyuk Bhin
, et al.
Supplementary Methods S7 from C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3
2026
·
Julia Yemelyanenko
, Jinhyuk Bhin
, et al.
Supplementary Figure S3 from C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3
2026
·
Julia Yemelyanenko
, Jinhyuk Bhin
, et al.
Supplementary Methods S5 from C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3
2026
·
Julia Yemelyanenko
, Jinhyuk Bhin
, et al.
Supplementary Methods S8 from C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3
2026
·
Julia Yemelyanenko
, Jinhyuk Bhin
, et al.
Supplementary Methods S4 from C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3
2026
·
Julia Yemelyanenko
, Jinhyuk Bhin
, et al.
Supplementary Table S1 from C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3
2026
·
Julia Yemelyanenko
, Jinhyuk Bhin
, et al.
Supplementary Figure S1 from C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3
2026
·
Julia Yemelyanenko
, Jinhyuk Bhin
, et al.
Supplementary Figure S4 from C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3
2026
·
Julia Yemelyanenko
, Jinhyuk Bhin
, et al.
Supplementary Methods S6 from C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3
2026
·
Julia Yemelyanenko
, Jinhyuk Bhin
, et al.
Supplementary Figure S6 from C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3
2026
·
Julia Yemelyanenko
, Jinhyuk Bhin
, et al.
Supplementary Methods S1 from C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3
2026
·
Julia Yemelyanenko
, Jinhyuk Bhin
, et al.
Supplementary Figure S2 from C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3
2026
·
Julia Yemelyanenko
, Jinhyuk Bhin
, et al.
Supplementary Figure S5 from C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3
2026
·
Julia Yemelyanenko
, Jinhyuk Bhin
, et al.
Supplementary Data S2 from C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3
2026
·
Julia Yemelyanenko
, Jinhyuk Bhin
, et al.
Data from C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3
2026
·
Julia Yemelyanenko
, Jinhyuk Bhin
, et al.
Supplementary Methods S2 from C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3
2026
·
Julia Yemelyanenko
, Jinhyuk Bhin
, et al.
Supplementary Figure S7 from C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3
2026
·
Julia Yemelyanenko
, Jinhyuk Bhin
, et al.
Beyond the chaos: How architecture structures tumour biology
2026
·
Lea Dörner
, Catrin Lutz
, et al.
·
FEBS Journal
Show more works
View as search
Works count:
24
Citation count:
5
H-index:
2
I10-index:
Year
Topic
Type